Hentapan, Angelita M.
HRN: 00-54-88 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/30/2026
METRONIDAZOLE 500MG (TAB)
06/30/2026
07/03/2026
PO
750
Q8hrs
AGE, DF WS
Pending Pharmacy Acceptance
Indication: Empiric Type of Infection: BloodstreamIntra-abdominal Compliance to guidelines: